Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 2022

View Archived Issues

OR5B21 is associated with breast cancer metastasis

Activation of ATF4 is required for DLBCL growth

Amgen discloses new SCN9A blockers

MCUF-651, a GC-A PAM for the treatment of cardiovascular, renal and metabolic diseases

Incyte divulges new ACVR1 inhibitors

Novartis presents new Cav1.2 activators

Vertex Pharmaceuticals identifies new APOL1 inhibitors

Merck & Co. synthesizes RIPK1 inhibitors

Discovery of novel selective and orally bioavailable AR-V7 degrader

Biogen exercises option to license preclinical ASO for spinal muscular atrophy

Dusquetide effective at reducing tumor size in nonclinical xenograft models

Novel covalent BTK inhibitor with good potency and reduced CYP inhibitory activity

Grant supports Cognition's evaluation of sigma-2 receptor modulators for Parkinson's disease

P-Esbp-DOX prolongs survival in mouse model of aggressive liver metastasis of colorectal cancer

Study of HT-ALZ shows decrease in Abeta in Alzheimer's disease mouse model after acute treatment

Seed funding at Ray Therapeutics supports development of RAY-001 for retinitis pigmentosa

NaNotics and Mayo Clinic collaborate on NaNot targeting soluble PD-L1

Insilico Medicine nominates preclinical candidates for IBD and anemia of CKD

Study shows nanoparticles could help reduce acute lung inflammation in COVID-19

Ideaya acquires INQUIRE chemical library

Tonix and Kansas State enter option agreement and research collaboration on LNP-free mRNA vaccines

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...